title: Factors affecting onchocerciasis transmission: lessons for infection control.
abstract: Onchocerca volvulus infects in excess of 15 million people. The vectors are Simulium blackflies, varieties of which differ in their ecologies, behavior and vectorial abilities. Control of the vectors and mass administrations of ivermectin have succeeded in reducing prevalences with elimination achieved in some foci, particularly in Central and southern America. In Africa, progress towards elimination has been less successful. Areas covered: Even with community directed treatment with ivermectin (CDTI), control has been difficult in African areas with initial prevalences in excess of 55%, especially if only annual treatments are dispensed. This is partly attributable to insufficient coverage, but the appearance of incipiently resistant non-responding parasites and lack of attention to vector biology in modeling and planning outcomes of intervention programmes have also played their parts, with recrudescence now appearing in some treated areas. Expert commentary: The biology of onchocerciasis is complex involving different vectors with differing abilities to transmit parasites, diverse pathologies related to geographical and parasite variations and endosymbionts in both parasite and vector. Modeling to predict epidemiological and control outcomes is addressing this complexity but more attention needs to be given to the vectors' roles to further understanding of where and when control measures will succeed.
authors.affiliation: a Agriculture, Health and Environment Department, Natural Resources Institute , University of Greenwich at Medway , Kent , UK.|b Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine (St Mary's campus) , Imperial College London , London , UK.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Cheke
mesh_terms: D000349:Africa / Q000453:epidemiology; D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D002489:Central America / Q000453:epidemiology; D004318:Doxycycline; D006801:Humans; D007303:Insect Vectors / Q000469:parasitology*; D007306:Insecticides; D007559:Ivermectin; D018942:Macrolides; D017181:Onchocerca volvulus / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D009855:Onchocerciasis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology / Q000635:transmission*; D012843:Simuliidae / Q000469:parasitology*; D013020:South America / Q000453:epidemiology
chemical_list: D000871:Anthelmintics; D007306:Insecticides; D018942:Macrolides; D007559:Ivermectin; D015766:Albendazole; D004318:Doxycycline; C027837:moxidectin
keywords: Onchocerca volvulus; Simulium damnosum complex; doxycycline; ivermectin; moxidectin; vector biology